Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience

Nephro-urology Monthly
Rizna Abdul CaderNorella Kong

Abstract

Coupled plasma filtration adsorption (CPFA) is a novel extracorporeal blood purification therapy for sepsis which adsorbs both proinflammatory and anti-inflammatory mediators from filtered plasma, thereby achieving early haemodynamic stability and a reduction in inotropic support requirement. The main objective was to review our centers' experience with CPFA in septic patients. A retrospective chart review of all septic patients who received CPFA was performed. All patients were initially treated according to the 'surviving sepsis care bundle' with fluid resuscitation, antibiotics, and inotropes as required. CPFA was started as soon as possible after a nephrologists' assessment. Twenty five patients with sepsis received CPFA (15 M, 10 F, mean age 49.60 ± 18.97 years). Comorbidities included hypertension (n = 10, 40%), diabetes mellitus (n = 6, 24%), ischemic heart disease (n = 6, 24%), and an immunosuppressed state (n = 10, 40%). All patients received one cycle of CPFA with median duration of 5 (1-10) hours. CPFA was well tolerated but we encountered technical problems, especially filter clotting as CPFA was performed heparin free. 14 (56%) patients died within 28 days of treatment. CRP correlated with PCT (P = 0.040) and had a...Continue Reading

References

Aug 1, 1989·Critical Care Medicine·J F HesselvikR Maller
Oct 1, 1989·Critical Care Medicine·P DamasP Franchimont
Feb 3, 1983·The New England Journal of Medicine·R V PinnickD A Diederich
Jun 1, 1997·Journal of Clinical Epidemiology·P Goldwasser, J Feldman
Jun 26, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C TettaG Lonnemann
Apr 9, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H U Meier-KriescheT D DuBose
Jun 2, 2000·Critical Care Medicine·C TettaR Giardino
Aug 11, 2001·Intensive Care Medicine·L ColeP Tipping
Aug 14, 2001·American Journal of Respiratory and Critical Care Medicine·S HarbarthUNKNOWN Geneva Sepsis Network
Feb 28, 2002·Blood Purification·R BellomoC Ronco
Jun 20, 2002·Critical Care Medicine·Claudio RoncoCiro Tetta
Dec 20, 2002·Nature·Jonathan Cohen
Mar 29, 2003·Intensive Care Medicine·Mitchell M LevyUNKNOWN International Sepsis Definitions Conference
Apr 1, 2003·Intensive Care Medicine·Marco FormicaCiro Tetta
Jun 10, 2003·Critical Care Medicine·Aldo LuzzaniAlberto Merlini
Jul 10, 2003·American Journal of Respiratory and Critical Care Medicine·Djillali AnnaneUNKNOWN CUB-Réa Network
Mar 5, 2004·Intensive Care Medicine·R Phillip DellingerM M Levy
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Rinaldo BellomoUNKNOWN Acute Dialysis Quality Initiative workgroup
Apr 28, 2007·Contributions to Nephrology·Marco FormicaMary Lou Wratten
Dec 17, 2008·Medicina intensiva·M F PrietoS M Pezzotto
Jun 24, 2009·Transplantation Proceedings·F SharifipourM Naghibi
Mar 20, 2013·Current Opinion in Pulmonary Medicine·Gauri Godbole, Vanya Gant

❮ Previous
Next ❯

Citations

Jan 16, 2016·Journal of Immunology Research·Stephan HarmJens Hartmann
Aug 28, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Filippo MarianoLuigi Biancone
Dec 1, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·B TuerdiG Li
Jun 1, 2020·Journal for Immunotherapy of Cancer·Catalin ConstantinescuCiprian Tomuleasa
Jun 3, 2015·World Journal of Gastroenterology : WJG·Hong-Liang Wang, Kai-Jiang Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.